Partial duplication of chromosome 17 syndrome

Partial duplication of chromosome 17 syndrome (also known as partial trisomy 17) is a rare chromosomal disorder in which a portion of chromosome 17 is duplicated, resulting in three copies of the genetic material in that segment rather than the usual two. The clinical presentation varies considerably depending on the size and specific location of the duplicated segment (short arm 17p, long arm 17q, or both). Common features may include intellectual disability, developmental delay, growth retardation, distinctive craniofacial features (such as a broad or prominent forehead, hypertelorism, low-set ears, micrognathia, and a flat nasal bridge), and various congenital anomalies. Skeletal abnormalities, cardiac defects, and hypotonia have also been reported in some cases. Because the phenotype depends heavily on which region of chromosome 17 is duplicated, there is significant clinical heterogeneity among affected individuals. Duplications involving the short arm (17p) may present differently from those involving the long arm (17q). Some patients have relatively mild manifestations, while others experience more severe multi-system involvement including seizures, feeding difficulties, and organ malformations. Diagnosis is typically established through chromosomal analysis, including karyotyping, fluorescence in situ hybridization (FISH), or chromosomal microarray analysis, which can precisely define the duplicated segment. There is currently no cure or specific targeted therapy for partial duplication of chromosome 17 syndrome. Management is supportive and symptomatic, tailored to the individual's specific clinical features. This may include early intervention programs, speech and occupational therapy, physical therapy for motor delays, cardiac monitoring or surgical correction of heart defects, and antiepileptic medications if seizures are present. A multidisciplinary team approach involving geneticists, pediatricians, neurologists, cardiologists, and developmental specialists is recommended to optimize outcomes and quality of life.

Common questions about Partial duplication of chromosome 17 syndrome